First Time Loading...

NuVasive Inc
NASDAQ:NUVA

Watchlist Manager
NuVasive Inc Logo
NuVasive Inc
NASDAQ:NUVA
Watchlist
Price: 39.75 USD Market Closed
Updated: May 6, 2024

NuVasive Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

NuVasive Inc
Cash from Operating Activities Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
NuVasive Inc
NASDAQ:NUVA
Cash from Operating Activities
$139.5m
CAGR 3-Years
-7%
CAGR 5-Years
-6%
CAGR 10-Years
4%
Becton Dickinson and Co
NYSE:BDX
Cash from Operating Activities
$3.4B
CAGR 3-Years
-8%
CAGR 5-Years
4%
CAGR 10-Years
8%
Boston Scientific Corp
NYSE:BSX
Cash from Operating Activities
$2.5B
CAGR 3-Years
10%
CAGR 5-Years
40%
CAGR 10-Years
8%
Stryker Corp
NYSE:SYK
Cash from Operating Activities
$3.5B
CAGR 3-Years
3%
CAGR 5-Years
6%
CAGR 10-Years
6%
Abbott Laboratories
NYSE:ABT
Cash from Operating Activities
$7.3B
CAGR 3-Years
-10%
CAGR 5-Years
4%
CAGR 10-Years
9%
Intuitive Surgical Inc
NASDAQ:ISRG
Cash from Operating Activities
$1.7B
CAGR 3-Years
2%
CAGR 5-Years
7%
CAGR 10-Years
8%

See Also

What is NuVasive Inc's Cash from Operating Activities?
Cash from Operating Activities
139.5m USD

Based on the financial report for Jun 30, 2023, NuVasive Inc's Cash from Operating Activities amounts to 139.5m USD.

What is NuVasive Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
4%

Over the last year, the Cash from Operating Activities growth was -18%. The average annual Cash from Operating Activities growth rates for NuVasive Inc have been -7% over the past three years , -6% over the past five years , and 4% over the past ten years .